, , , , , , e.a.

Hereditary Retinopathies

Progress in Development of Genetic and Molecular Therapies

Specificaties
Paperback, 46 blz. | Engels
Springer New York | 2012e druk, 2012
ISBN13: 9781461444985
Rubricering
Juridisch :
Springer New York 2012e druk, 2012 9781461444985
Onderdeel van serie SpringerBriefs in Genetics
€ 61,99
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Samenvatting

The hereditary retinopathy, retinitis pigmentosa (RP), which affects 1 in 3,500 people worldwide, is the most common cause of registered visual handicap among those of the working age in developed countries. RP is a highly variable disorder where patients may develop symptomatic visual loss in early childhood, while others may remain asymptomatic until mid-adulthood. Most cases of RP segregate in autosomal dominant, recessive or X-linked recessive modes, with approximately 41 genes being implicated in disease pathology to date (RetNet). The extensive genetic heterogeneity associated with autosomal dominant RP (adRP) is an undisputed hindrance to the development of genetically based therapeutics.

Specificaties

ISBN13:9781461444985
Taal:Engels
Bindwijze:paperback
Aantal pagina's:46
Uitgever:Springer New York
Druk:2012

Inhoudsopgave

Preface.- Introduction.- Gene-based Medicines directly targeting genetic defects and molecular pathologies common to multiple forms of disease.- Molecular Medicines.

Net verschenen

€ 61,99
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Rubrieken

    Personen

      Trefwoorden

        Hereditary Retinopathies